ArticleMaterials (Basel, Switzerland)2025
Durable Mortar Mixes Using 50% of Activated Volcanic Ash as A Binder.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Assessment of Physical Properties and Potential Elemental Leaching from Bauxite Tailing-Based Alkali-Activated Materials.ACS omega · 2026Article
- Sustainable Use of Volcanic Ash in Mortars as a Replacement for Cement or Sand: Shrinkage and Physical and Mechanical Properties.Materials (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Volcanic ash (VA) is an abundant resource in many world regions that can be used as a supplementary cementitious material (SCM). However, its low reactivity limits its applications as a replacement for Portland cement. In this study, the improvement of its reactivity was evaluated through the calcination of VA (CVA) at 700 °C, alkali activation with Na
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.